Aplenzin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0187-5812 -
Package NDC
0187-5812-07 -
Package NDC
0187-5812-30 -
Application number
NDA022108 -
SPL ID
45372e42-065d-4d87-89af-d5dcf09c29fb -
SPL set ID
6494d2d9-0ce4-4126-b1c7-49684395942b -
UNII
E70G3G5863 -
RxCUI
993550 -
RxCUI
993552 -
RxCUI
993567 -
RxCUI
993569 -
RxCUI
993681 -
RxCUI
993683
What the source publishes
- Labeler
- Bausch Health US, LLC
- Active ingredients
- bupropion hydrobromide
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Aplenzin",
"splId": "45372e42-065d-4d87-89af-d5dcf09c29fb",
"labels": [
{
"setId": "6494d2d9-0ce4-4126-b1c7-49684395942b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6494d2d9-0ce4-4126-b1c7-49684395942b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6494d2d9-0ce4-4126-b1c7-49684395942b"
}
],
"routes": [
"ORAL"
],
"labeler": "Bausch Health US, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-07)",
"package_ndc": "0187-5812-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20080423"
},
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-30)",
"package_ndc": "0187-5812-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20080423"
}
],
"productId": "0187-5812_45372e42-065d-4d87-89af-d5dcf09c29fb",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "0187-5812",
"deaSchedule": null,
"genericName": "bupropion hydrobromide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BUPROPION HYDROBROMIDE",
"strength": "522 mg/1"
}
],
"applicationNumber": "NDA022108",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20080423",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0301875810306",
"0301875811303"
],
"unii": [
"E70G3G5863"
],
"rxcui": [
"993550",
"993552",
"993567",
"993569",
"993681",
"993683"
],
"spl_set_id": [
"6494d2d9-0ce4-4126-b1c7-49684395942b"
],
"manufacturer_name": [
"Bausch Health US, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0187-5812_45372e42-065d-4d87-89af-d5dcf09c29fb"